Individual patients with severe neurological autoimmune diseases have been treated in Germany with CD19 CAR T-cell therapy EMERYVILLE, Calif., Nov. 10, 2023 /PRNewswire/ — Kyverna Therapeutics (“Kyverna”), a patient-centered clinical-stage biopharmaceutical company focused on developing…
